KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITDAProfit After TaxShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

QuidelOrtho (QDEL) EBITDA (2021 - 2025)

QuidelOrtho's EBITDA history spans 4 years, with the latest figure at $1.2 million for Q3 2024.

  • For Q3 2024, EBITDA rose 102.42% year-over-year to $1.2 million; the TTM value through Sep 2024 reached -$693.4 million, down 305.45%, while the annual FY2025 figure was -$1.1 billion, 46.02% up from the prior year.
  • EBITDA for Q3 2024 was $1.2 million at QuidelOrtho, up from -$618.1 million in the prior quarter.
  • Across five years, EBITDA topped out at $620.7 million in Q2 2022 and bottomed at -$618.1 million in Q4 2023.
  • The 4-year median for EBITDA is $56.8 million (2022), against an average of $118.9 million.
  • The largest annual shift saw EBITDA soared 1889.7% in 2022 before it plummeted 296.6% in 2023.
  • A 4-year view of EBITDA shows it stood at $423.1 million in 2021, then crashed by 86.58% to $56.8 million in 2022, then plummeted by 1188.2% to -$618.1 million in 2023, then skyrocketed by 100.19% to $1.2 million in 2024.
  • Per Business Quant, the three most recent readings for QDEL's EBITDA are $1.2 million (Q3 2024), -$618.1 million (Q4 2023), and -$49.6 million (Q4 2023).